Total de visites
| Visites | |
|---|---|
| Tepotinib ... | 39 |
Total de visites per mes
| de novembre 2023 | de desembre 2023 | de gener 2024 | de febrer 2024 | de març 2024 | d’abril 2024 | de maig 2024 | |
|---|---|---|---|---|---|---|---|
| Tepotinib ... | 0 | 0 | 1 | 1 | 2 | 9 | 1 |
Total de descàrregues del fitxer
| Visites | |
|---|---|
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022.pdf | 20 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_material_suplementari1.pdf | 13 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_material_suplementari2.pdf | 13 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura6.pdf | 11 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura5.pdf | 10 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura7.pdf | 8 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura3.pdf | 8 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura4.pdf | 7 |
| functional_mapping_akt_signaling_biomarkers_response_fairlane_trial_neoadjuvant_ipatasertib_plus_paclitaxel_triple_negative_breast_cancer_2022_figura2.pdf | 7 |
| tepotinib_efficacy_safety_patients_met_exon_14_skipping_nsclc_outcomes_patient_subgroups_vision_study_relevance_clinical_practice_2022_figura8.pdf | 7 |
Visites per país
| Visites | |
|---|---|
| Estats Units | 27 |
| Alemanya | 6 |
| Irlanda | 2 |
| Espanya | 1 |
| França | 1 |
| Regne Unit | 1 |
| Japó | 1 |
Visites per ciutat
| Visites | |
|---|---|
| Social Circle | 4 |
| Springfield | 3 |
| The Dalles | 3 |
| Boardman | 2 |
| Dublin | 2 |
| Ashburn | 1 |
| Barcelona | 1 |
| Darmstadt | 1 |
| Fort Worth | 1 |
| London | 1 |